Precursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity.

TitlePrecursor central memory versus effector cell fate and naïve CD4+ T cell heterogeneity.
Publication TypeJournal Article
Year of Publication2024
AuthorsDeep D, Gudjonson H, Brown CC, Rose SA, Sharma R, Iza YAPaucar, Hong S, Hemmers S, Schizas M, Wang Z-M, Chen Y, Wesemann DR, Pascual V, Pe'er D, Rudensky AY
JournalJ Exp Med
Volume221
Issue10
Date Published2024 Oct 07
ISSN1540-9538
KeywordsAnimals, CD4-Positive T-Lymphocytes, Cell Differentiation, Humans, Immunologic Memory, Interferon Type I, Lymphocyte Activation, Memory T Cells, Mice
Abstract

Upon antigenic stimulation, naïve CD4+ T cells can give rise to phenotypically distinct effector T helper cells and long-lived memory T cells. We computationally reconstructed the in vivo trajectory of CD4+ T cell differentiation during a type I inflammatory immune response and identified two distinct differentiation paths for effector and precursor central memory T cells arising directly from naïve CD4+ T cells. Unexpectedly, our studies revealed heterogeneity among naïve CD4+ T cells, which are typically considered homogeneous save for their diverse T cell receptor usage. Specifically, a previously unappreciated population of naïve CD4+ T cells sensing environmental type I IFN exhibited distinct activation thresholds, suggesting that naïve CD4+ T cell differentiation potential may be influenced by environmental cues. This population was expanded in human viral infection and type I IFN response-lined autoimmunity. Understanding the relevance of naïve T cell heterogeneity to beneficial and maladaptive T cell responses may have therapeutic implications for adoptive T cell therapies in cancer immunotherapy and vaccination.

DOI10.1084/jem.20231193
Alternate JournalJ Exp Med
PubMed ID39321257
PubMed Central IDPMC11448869
Grant ListT32GM007739 / GM / NIGMS NIH HHS / United States
R01 AI139538 / AI / NIAID NIH HHS / United States
U54-CA209975 / CA / NCI NIH HHS / United States
T32 AI007306 / AI / NIAID NIH HHS / United States
R01 AI121394 / NH / NIH HHS / United States
R01 A1034206 / / National Institute of Allergy and Infectious Diseases /
P30 CA008748 / CA / NCI NIH HHS / United States
R01 AI121394 / AI / NIAID NIH HHS / United States
/ WT_ / Wellcome Trust / United Kingdom
P30CA008748 / / Memorial Sloan Kettering /
/ / Weill Cornell /
/ / Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center /
WT201483/Z/16/Z / WT_ / Wellcome Trust / United Kingdom
/ HHMI / Howard Hughes Medical Institute / United States
F30 AI154660 / AI / NIAID NIH HHS / United States
T32 GM007205 / GM / NIGMS NIH HHS / United States
R25 GM130494 / GM / NIGMS NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
U54 CA209975 / CA / NCI NIH HHS / United States
/ / Parker Institute for Cancer Immunotherapy /

Person Type: